These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25115926)

  • 1. Role of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV.
    Aldred KJ; Breland EJ; Vlčková V; Strub MP; Neuman KC; Kerns RJ; Osheroff N
    Biochemistry; 2014 Sep; 53(34):5558-67. PubMed ID: 25115926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance.
    Aldred KJ; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    Nucleic Acids Res; 2013 Apr; 41(8):4628-39. PubMed ID: 23460203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Water-Metal Ion Bridge in Quinolone Interactions with
    Carter HE; Wildman B; Schwanz HA; Kerns RJ; Aldred KJ
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
    Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge.
    Aldred KJ; Breland EJ; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7182-7. PubMed ID: 25246407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.
    Aldred KJ; McPherson SA; Wang P; Kerns RJ; Graves DE; Turnbough CL; Osheroff N
    Biochemistry; 2012 Jan; 51(1):370-81. PubMed ID: 22126453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV. Changes in drug mechanism across evolutionary boundaries.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    J Biol Chem; 1999 Dec; 274(50):35927-32. PubMed ID: 10585479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions.
    Hiasa H
    Biochemistry; 2002 Oct; 41(39):11779-85. PubMed ID: 12269820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.
    Aldred KJ; Schwanz HA; Li G; Williamson BH; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    Biochemistry; 2015 Feb; 54(5):1278-86. PubMed ID: 25586498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV.
    Tran JH; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3050-2. PubMed ID: 15980397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
    Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.
    Hoshino K; Kitamura A; Morrissey I; Sato K; Kato J; Ikeda H
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2623-7. PubMed ID: 7872758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase IV is a target of quinolones in Escherichia coli.
    Khodursky AB; Zechiedrich EL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11801-5. PubMed ID: 8524852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV.
    Pitts SL; Liou GF; Mitchenall LA; Burgin AB; Maxwell A; Neuman KC; Osheroff N
    Nucleic Acids Res; 2011 Jun; 39(11):4808-17. PubMed ID: 21300644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug Resistance.
    Ashley RE; Lindsey RH; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    Biochemistry; 2017 Aug; 56(32):4191-4200. PubMed ID: 28708938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.